This is a phase I, open-label, multiple-dose, dose-escalation study to evaluate the safety,
tolerability, pharmacokinetics and anti-tumor activity of LDP in subjects with advanced
This trial is an open, dose escalation phase I clinical trial study of patients with advanced
cancer who have failed standard treatment. The trial is divided into a dose escalation phase
and an expansion phase.
Approximately 130 patients will be enrolled in this trial. The dose-increasing phase is about
30 cases, and the expansion stage is about 100 cases.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.